CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 261 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $673 | +216.0% | 57,626 | +262.9% | 0.01% | +250.0% |
| Q2 2023 | $213 | -94.2% | 15,879 | -92.9% | 0.00% | -95.6% |
| Q1 2023 | $3,683 | +480.9% | 222,178 | +551.5% | 0.04% | +400.0% |
| Q4 2022 | $634 | -99.9% | 34,105 | +2.7% | 0.01% | +80.0% |
| Q3 2022 | $426,000 | -67.7% | 33,217 | -82.3% | 0.01% | -64.3% |
| Q2 2022 | $1,318,000 | +47.1% | 188,119 | +42.1% | 0.01% | +180.0% |
| Q4 2021 | $896,000 | +409.1% | 132,366 | +296.5% | 0.01% | +400.0% |
| Q3 2021 | $176,000 | -51.5% | 33,380 | -69.3% | 0.00% | -85.7% |
| Q4 2020 | $363,000 | +57.8% | 108,714 | +117.9% | 0.01% | 0.0% |
| Q2 2020 | $230,000 | – | 49,888 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
| Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
| Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
| CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
| Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
| Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
| AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
| KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |